3-aminobenzamide has been researched along with Peripheral Nervous System Diseases in 1 studies
Peripheral Nervous System Diseases: Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Komirishetty, P | 1 |
| Areti, A | 1 |
| Yerra, VG | 1 |
| Ruby, PK | 1 |
| Sharma, SS | 1 |
| Gogoi, R | 1 |
| Sistla, R | 1 |
| Kumar, A | 1 |
1 other study available for 3-aminobenzamide and Peripheral Nervous System Diseases
| Article | Year |
|---|---|
PARP inhibition attenuates neuroinflammation and oxidative stress in chronic constriction injury induced peripheral neuropathy.
Topics: Animals; Benzamides; Constriction, Pathologic; Cyclooxygenase 2; Hyperalgesia; Inflammation; Male; N | 2016 |